State Street Corp Enzo Biochem Inc Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Enzo Biochem Inc stock. As of the latest transaction made, State Street Corp holds 168,881 shares of ENZ stock, worth $87,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,881

Previous 154,139 9.56%

Holding current value

$87,818

Previous $172,000 30.81%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.7 - $1.17 $10,319 - $17,248	14,742 Added 9.56%	168,881 $119,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.5 $15,609 - $19,350	-12,900 Reduced 7.72%	154,139 $195,000
Q2 2023 Aug 14, 2023	SELL	$1.84 - $2.66 $31,464 - $45,486	-17,100 Reduced 9.29%	167,039 $307,000
Q4 2022 Feb 14, 2023	SELL	$1.16 - $2.42 $1,739 - $3,630	-1,500 Reduced 0.81%	184,139 $263,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $3.0 $24,988 - $37,482	-12,494 Reduced 6.31%	185,639 $384,000
Q1 2022 May 16, 2022	BUY	$2.9 - $3.47 $8,059 - $9,643	2,779 Added 1.42%	198,133 $575,000
Q2 2021 Aug 16, 2021	SELL	$2.86 - $3.61 $1.72 Million - $2.18 Million	-602,964 Reduced 75.53%	195,354 $619,000
Q1 2021 May 17, 2021	SELL	$2.61 - $4.08 $128,485 - $200,850	-49,228 Reduced 5.81%	798,318 $2.75 Million
Q4 2020 Feb 16, 2021	BUY	$1.82 - $2.61 $69,456 - $99,605	38,163 Added 4.72%	847,546 $2.14 Million
Q3 2020 Nov 10, 2020	BUY	$2.02 - $3.02 $6,688 - $9,999	3,311 Added 0.41%	809,383 $1.71 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.22 $100,572 - $152,756	47,440 Added 6.25%	806,072 $1.81 Million
Q1 2020 May 11, 2020	BUY	$1.82 - $3.87 $1.38 Million - $2.94 Million	758,632 New	758,632 $1.92 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

16.6M

Call Options Held

18.3K

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $25.3M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Enzo Biochem Inc Transaction History